Selective Activation of Nuclear PI-PLCbeta1 During Normal and Therapy-Related Differentiation
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
2345-2348
Author(s):
Sara Mongiorgi, Matilde Y. Follo, Yong Ryoul Yang, Stefano Ratti, Lucia Manzoli, James A. McCubrey, Anna Maria Billi, Pann-Ghill Suh and Lucio Cocco
Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
2323-2332
Author(s):
Anna Mies, Ekaterina Bulycheva, Inga Mandac Rogulj, Lorenz C. Hofbauer and Uwe- Platzbecker
New Functions of the Inositol Polyphosphate 5-Phosphatases in Cancer
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
2309-2314
Author(s):
Christophe Erneux, Somadri Ghosh, Ana Raquel Ramos and William`s Elong Edimo
Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
2315-2322
Author(s):
Marie Levade, Sonia Severin, Marie-Pierre Gratacap, Loïc Ysebaert and Bernard Payrastre
Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
11
Page:
141-151
Author(s):
Xiao-Na Fang and Li-Wu Fu
Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing Chemoresistance
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
686-698
Author(s):
Jan Hrabeta, Vojtech Adam, Tomas Eckschlager, Eva Frei, Marie Stiborova and Rene Kizek
Tannic Acid Inhibits Proliferation, Migration, Invasion of Prostate Cancer and Modulates Drug Metabolizing and Antioxidant Enzymes
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
781-789
Author(s):
Serdar Karakurt and Orhan Adali
Current Status of Epigenetics and Anticancer Drug Discovery
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
699-712
Author(s):
Ping Jin and Xiaofei Chen
Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies
Journal:
Current Drug Targets
Volume:
17
Page:
824-849
Author(s):
Stefano Thellung, Roberto E. Favoni, Roberto Würth, Mario Nizzari, Alessandra Pattarozzi, Antonio Daga, Tullio Florio and Federica Barbieri
The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Journal:
Current Molecular Medicine
Volume:
16
Page:
353-393
Author(s):
T.F. Sumter, L. Xian, T. Huso, M. Koo, Y.-T. Chang, T.N. Almasri, L. Chia, C. Inglis, D. Reid and L.M.S. Resar